Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
New York court dismisses most of Teva claims against Mexican drugmakers | The Times of Israel
Does Teva Pharmaceutical Industries (NYSE:TEVA) Have A Healthy Balance Sheet? | Nasdaq
Teva Gains 6.4% on Another Opioid Case Settlement - TipRanks.com
TEVA stock on watch as CEO comments on opioid deal (NYSE:TEVA) | Seeking Alpha
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product
Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026 | Business Wire
Leading Global Pharmaceutical Company, Teva Pharmaceutical Industries, Transfers Stock Listing to the New York Stock Exchange from NASDAQ | Business Wire
Teva Pharmaceutical: Slow Road To A Higher Share Price (NYSE:TEVA) | Seeking Alpha